For the last 8 months or so, I've been part of a research lab on campus. Our lab studies acetylcholine receptors, which are proteins in the body whose function has to do with both movement and cognition, among other things. In our research, we study the effects of another protein, beta-amyloid, on the acetylcholine receptor. Beta-amyloid is a protein whose misfolding causes much of the pathology and neurodegeneration seen in Alzheimer's disease. When beta-amyloid folds the wrong way, it causes other beta-amyloid copies to fold improperly as well, amplifying the degenerative effect. We hope to characterize beta-amyloid's effect on the acetylcholine receptor to better understand the pathology of Alzheimer's.
Of course, this is only a piece of the puzzle. Alzheimer's is a problem that encompasses many molecular players in the brain, which is why so many scientists are working on it right now. With the scope of the problem so wide, it's hard to feel like your work is making a difference. In fact, it may not be; it's possible that the key to curing Alzheimer's is something my current lab isn't associated with right now. Even when labs develop drugs or other therapies that look promising for the treatment of Alzheimer's or other neurodegenerative diseases, there's still the problem of getting them across the blood-brain barrier (BBB), which excludes many molecules from entering the brain (for a good reason, of course, but it makes drug research difficult).
A couple weeks ago, for my advanced neuroscience class, we read a couple journal articles about the difficulties in getting drugs across the BBB and several ways of getting around it. Some of them seem to do more harm than good, but more recent techniques show promise. One of these techniques involves introducing a pathological protein like beta-amyloid with an immunologic adjuvant (an adjuvant is something that stimulates an immune response). The adjuvant both activates the immune system and disrupts the BBB so that beta-amyloid can get across. But why do we want to put a disease-causing protein in the brain? Well, while the BBB is disrupted, the immune system is making antibodies against beta-amyloid. Normally, this wouldn't matter, because if the antibodies can't get into the brain where the problem is, nothing gets solved. But because of the adjuvant, antibodies for beta-amyloid are introduced into the brain. And, theoretically, if we could properly introduce these antibodies without overly raising levels of beta-amyloid, it would be like a vaccine for Alzheimer's. A VACCINE. FOR ALZHEIMER'S.
Yep. You heard me right.
Before anyone comes up with conspiracy theories about why this promising technology isn't already being distributed to everybody, understand that there's more that has to be done before this kind of a thing is ready to be safely and effectively used in humans. But if this is modified to the point that it reliably and repeatedly works, it would solve one of the most expensive and debilitating medical problems in this country. Not only solve it, but prevent it. I haven't read much more about it since then, but it's very possible that the blood-brain barrier will be a major research focus of mine for my scientific career. Whatever I end up doing, I want my research to help alleviate suffering. I may just be working on a small piece of the puzzle for the rest of my life, not contributing in any noticeable way to any major problems. But if something I discover helps somebody else to discover something that changes the world, I'm okay with that. Because I did my part.